Identification of a novel conformationally constrained glucagon receptor antagonist-Reference-Cited by-同舟云学术

Identification of a novel conformationally constrained glucagon receptor antagonist

Published:2014-02 Issue:3 Volume:24 Page:839-844
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Lee Esther C.Y.,Tu Meihua,Stevens Benjamin D.,Bian Jianwei,Aspnes Gary,Perreault Christian,Sammons Matthew F.,Wright Stephen W.,Litchfield John,Kalgutkar Amit S.,Sharma Raman,Didiuk Mary T.,Ebner David C.,Filipski Kevin J.,Brown Janice,Atkinson Karen,Pfefferkorn Jeffrey A.,Guzman-Perez Angel

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference26 articles.

1. New Drugs for Type 2 Diabetes Mellitus

2. Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes

3. (b) Diabetes Obes. Metab. 2011, 13, 965.

4. Glucagon Receptor Antagonists for Type II Diabetes

5. A survey of small molecule glucagon receptor antagonists from recent patents (2006 – 2010)

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of 1,5-Substituted Pyrrolidin-2-ones from Donor–Acceptor Cyclopropanes and Anilines/Benzylamines;Molecules;2022-12-02

2. Ring expansion of donor—acceptor cyclopropanes bearing arylcarbamoyl group into 1,5-diarylpyrrolidin-2-ones;Russian Chemical Bulletin;2022-11

3. Ambident reactivity of 5-aminopyrazoles towards donor–acceptor cyclopropanes;Organic & Biomolecular Chemistry;2022

4. Synthesis and anti‐diabetic activity of novel biphenylsulfonamides as glucagon receptor antagonists;Chemical Biology & Drug Design;2021-08

5. Reduction of 2-hydroxy-3-arylmorpholines to 3-aryl morpholines;Tetrahedron;2020-06